HomeCompareCRGE vs MRK

CRGE vs MRK: Dividend Comparison 2026

CRGE yields 9523.81% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CRGE wins by $34096885384495640.00M in total portfolio value
10 years
CRGE
CRGE
● Live price
9523.81%
Share price
$0.02
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34096885384495640.00M
Annual income
$33,406,863,634,510,780,000,000.00
Full CRGE calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — CRGE vs MRK

📍 CRGE pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCRGEMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CRGE + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CRGE pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CRGE
Annual income on $10K today (after 15% tax)
$809,523.81/yr
After 10yr DRIP, annual income (after tax)
$28,395,834,089,334,163,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, CRGE beats the other by $28,395,834,089,334,163,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CRGE + MRK for your $10,000?

CRGE: 50%MRK: 50%
100% MRK50/50100% CRGE
Portfolio after 10yr
$17048442692247820.00M
Annual income
$16,703,431,817,255,390,000,000.00/yr
Blended yield
97.98%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CRGE
Analyst Ratings
1
Buy
1
Hold
Consensus: Buy
Altman Z
1.4
Piotroski
5/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CRGE buys
0
MRK buys
0
No recent congressional trades found for CRGE or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCRGEMRK
Forward yield9523.81%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$34096885384495640.00M$56.8K
Annual income after 10y$33,406,863,634,510,780,000,000.00$9,798.13
Total dividends collected$34050931359582140.00M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusBuyBuy

Year-by-year: CRGE vs MRK ($10,000, DRIP)

YearCRGE PortfolioCRGE Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$963,081$952,380.95$11,206$366.19+$951.9KCRGE
2$86,751,988$85,721,491.09$12,650$502.35+$86.74MCRGE
3$7,309,257,562$7,216,432,935.10$14,407$694.19+$7309.24MCRGE
4$576,061,994,112$568,241,088,520.80$16,585$967.82+$576061.98MCRGE
5$42,471,142,252,811$41,854,755,919,110.81$19,342$1,363.89+$42471142.23MCRGE
6$2,929,381,022,509,453$2,883,936,900,298,945.50$22,913$1,947.19+$2929381022.49MCRGE
7$189,036,367,688,831,520$185,901,929,994,746,400.00$27,662$2,823.89+$189036367688.80MCRGE
8$11,413,921,216,762,330,000$11,211,652,303,335,279,000.00$34,159$4,173.35+$11413921216762.29MCRGE
9$644,880,140,172,767,400,000$632,667,244,470,831,700,000.00$43,337$6,308.80+$644880140172767.38MCRGE
10$34,096,885,384,495,640,000,000$33,406,863,634,510,780,000,000.00$56,776$9,798.13+$34096885384495640.00MCRGE

CRGE vs MRK: Complete Analysis 2026

CRGEStock

Charge Enterprises Inc. engages in building the electrification and telecommunications infrastructure for electric vehicle charging(EVC) and wireless network infrastructure, including 5G, tower, distributed antennae systems, small cell, and electrical infrastructure. The company operates through Telecommunications and Infrastructure segments. Its Telecommunications segment offers internet-protocol-based and time-division multiplexing access for transport of long-distance voice and data minutes; domestic switching and related peripheral equipment services, and carrier-grade routers and switches for internet and circuit-based services, as well as connection of voice calls and data services. The company's Infrastructure segment focuses on physical wireless networking elements including 4G and 5G, cell tower, small cell, and in-building applications and EVC solutions including design, engineering, vendor specification, construction, installation, and maintenance of electric vehicle chargers. This segment also offers network of personal charging power banks situated in bars, restaurants, transit hubs, and sporting arenas. The company was formerly known as TransWorld Holdings Inc and changed its name to Charge Enterprises, Inc. in January 2021.Charge Enterprises, Inc. was incorporated in 2003 and is based in New York, New York.

Full CRGE Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CRGE vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CRGE vs SCHDCRGE vs JEPICRGE vs OCRGE vs KOCRGE vs MAINCRGE vs JNJCRGE vs ABBVCRGE vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.